Blog page examines global malaria funding In a post in his ‘Malaria Matters’ blog, Bill Brieger, a professor in medical systems plan of the department of worldwide health at Johns Hopkins University, examines donor funding for global health insurance and asks whether funding for malaria has reach a plateau. This content was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family members Foundation.John Letterio, Case Western Reserve University College of Medicine By April Cashin-Garbutt Interview conducted, BA Hons Dr. John LetterioTHOUGHT LEADERS SERIES. The strategy involves the use of either pharmacologic or organic brokers that inhibit the advancement of invasive malignancy either by blocking the DNA harm that initiates carcinogenesis or by arresting or reversing the progression of premalignant cells in which such damage has already occurred. How much progress has been made since that time? Michael Sporn coined the term chemoprevention in a 1976 content in Federation Proceedings when authoring the task his group was carrying out with vitamin A analogues. Dr. Sporn, then a known person in the Carcinogenesis System at the National Cancer Institute, led the first work with agents that could be used to avoid cancer.